Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Gold Fields Completes AU$3.7 Billion Acquisition of Gold Road

by admin October 20, 2025
October 20, 2025
Gold Fields Completes AU$3.7 Billion Acquisition of Gold Road

Gold Fields (NYSE:GFI) has completed its AU$3.7 billion purchase of Gold Road Resources.

Gold Road rejected Gold Fields’ first acquisition proposal in March, saying it undervalued the company.

Following negotiations between the two parties, Gold Fields, through its wholly owned entity Gruyere Holdings, entered into a scheme implementation deed with Gold Road on May 5. Under the AU$3.7 billion deal, the companies agreed that Gold Road shareholders would receive fixed cash consideration of AU$2.52 per share.

‘The Scheme provides Gold Road shareholders with an opportunity to realise certain value for their Gold Road shares at a compelling premium,” said Gold Road Managing Director and CEO Duncan Gibbs at the time.

“This offer price represents a material premium to the undisturbed share price prior to the initial Gold Fields’ proposal and a material premium to longer term trading levels,’ he added.

Under the deal, Gold Fields will gain a 100 percent interest in the Gruyere project in Western Australia.

Gruyere, which the companies previously worked on together as a joint venture, currently holds an open-pit mineral resource of 6.04 million ounces, and ore reserves of 3.67 million ounces.

Its average annual gold production stands at at 350,000 ounces.

According to Gold Fields, all Gold Road shares are now owned by Gruyere Holdings. Following the scheme’s implementation, Gold Road is expected to apply to delist from the Australian Securities Exchange.

Securities Disclosure: I, Gabrielle de la Cruz, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
China, US Rare Earths Tensions Ramp Up Ahead of Trump-Xi Meeting
next post
DAN GAINOR: The England we love is lost. If we don’t change, America will be, too

Related Posts

Boundiali Resource Grows to 3Moz – Indicated Up...

February 23, 2026

Quimbaya Gold Completes Final Payment on Four Tahami...

March 13, 2025

Syntholene Energy Selects Dynelectro, Developer of “World’s Most...

February 10, 2026

CoTec to Host Investor Update

January 14, 2026

Sarama Completes Tranche 2 Options Placement

February 11, 2025

Homerun Resources: Establishing a Vertically Integrated Leader in...

August 20, 2025

Trump Weighs Executive Order to Loosen Federal Cannabis...

December 16, 2025

1911 Gold Temporarily Suspends Operations at True North...

May 31, 2025

Hydrogeological Testing Underway at Lo Herma

November 19, 2025

Crypto Price Update: Q1 2025 in Review

April 7, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved